Global burden of tuberculous meningitis in children aged 0-14 years in 2019: a mathematical modelling study

Karen du Preez1, Helen E Jenkins2, Leonardo Martinez3

  • 1Desmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.

The Lancet. Global Health
|December 20, 2024
PubMed

Insights

An estimated 24,000 children developed tuberculous meningitis in 2019, with over 16,000 deaths. Early diagnosis and treatment are crucial for improving outcomes in childhood tuberculous meningitis.

Area of Science:

  • Global health
  • Epidemiology
  • Infectious diseases

Background:

  • Tuberculous meningitis is a severe, often fatal, neurological condition in children.
  • Limited data exist on the global burden of childhood tuberculous meningitis.
  • Estimating disease burden is critical for public health interventions.

Purpose of the Study:

  • To estimate the global disease burden and mortality of childhood tuberculous meningitis in 2019.
  • To analyze these estimates by WHO regions, age groups, treatment status, and HIV status.
  • To provide data for informing public health strategies and resource allocation.

Main Methods:

  • A Bayesian mathematical model was developed to estimate cases, deaths, and sequelae.
  • Literature reviews and meta-analyses quantified key parameters, including infection risk and case-fatality rates.
  • Utilized tuberculosis surveillance data from various countries and aggregated regional data.

Main Results:

  • An estimated 24,000 children (0-14 years) developed tuberculous meningitis in 2019.
  • Approximately 16,100 deaths were attributed to tuberculous meningitis, with most occurring in children under 5 and those untreated.
  • Over 5,500 survivors experienced neurological sequelae.

Conclusions:

  • Childhood tuberculous meningitis represents a significant global health challenge with high mortality and morbidity.
  • Improved diagnostics and robust healthcare systems are essential for early detection and better outcomes.
  • Tuberculosis prevention strategies must be prioritized as a public health imperative.
Abstract

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
303
Probability Laws01:49

Probability Laws

Overview
40.0K